PT-141 (bremelanotide) is a synthetic peptide that treats sexual dysfunction by acting directly on the brain’s hypothalamus to increase sexual desire. Unlike Viagra or Cialis (which manage blood flow), PT-141 serves as an "ignition" for libido in both men and women.
How it Works
PT-141 is a melanocortin receptor agonist. It targets the central nervous system to turn the "volume knob" up on arousal and natural desire, rather than just forcing a physical erection or physiological response .
For Men: It is primarily prescribed off-label for low libido and erectile dysfunction where vascular-based drugs (like PDE5 inhibitors) are ineffective.
For Women: It is officially FDA-approved (under the brand name Vyleesi) to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women.
Administration and Timing
Delivery: Administered either via subcutaneous injection (often in the abdomen or thigh) or as a sublingual troche.
Timing: It takes about 45 minutes to 2 hours to reach its full effect . Once active, the effects can last anywhere from 4 to 12 hours.
Side Effects and Considerations
As with any peptide therapy, there are potential risks and side effects to keep in mind, including:
Nausea: This is the most frequently reported side effect and is entirely dose-dependent .
Flushing: Warmth in the face and chest is common shortly after administration .
Blood Pressure: PT-141 can temporarily raise systolic blood pressure, meaning it requires careful monitoring for those with pre-existing cardiovascular conditions.
How to Access
For women dealing with HSDD, you can obtain a prescription for Vyleesi directly from your healthcare provider. For other off-label uses—such as male libido—PT-141 is accessed through compounding pharmacies via specialized medical professionals, men's health clinics, or hormone therapy specialists.
This is for informational purposes only. For medical advice or diagnosis, consult a professional.
This product for research use only.